Complix to Present at Upcoming BioEquity Europe 2013: http://t.co/jzPUX0k7Bp
posted
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
Movetis NV (MOVE), the European gastrointestinal (GI) speciality pharmaceutical company, announces today that it has started a phase III clinical trial with prucalopride in male patients with chronic constipation. Positive results from this clinical trial programme should allow Movetis to support a regulatory application for expansion of the current label of Resolor® (prucalopride)(1). read more
OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA), a leading molecular diagnostics company, announced today that it has entered into an agreement with GlaxoSmithKline Biologicals S.A. (GSK) for the potential use of one of its DNA methylation specific PCR biomarkers in GSKs immunotherapy development program. Additional financial details were not disclosed. read more
De achtste editie van de ondernemingsplanwedstrijd Enterprize toont aan dat creatief ondernemerschap meer dan ooit aanwezig is in België. Bij de winnaars van 2010 vinden we zeer uiteenlopende en creatieve initiatieven terug. Verschillende initiatieven tonen duidelijk aan dat ook ideeën met respect voor milieu en energie gepaard kunnen gaan met economisch succes. read more
TiGenix (NYSE EURONEXT: TIG) announces that it has been awarded a new research grant for the development of its collagen biomaterials platform bringing the total grant funding for its UK subsidiary this year to GBP 0.8 million. read more
